Koichi Miyamura

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Shigeki Ohtake, Shuichi Miyawaki, Hiroyuki Fujita et al. · Blood · 2010 · 262 citations · Full text

Medicine, Oncology, Pharmacology +15

A Genetic Variant in the IL-17 Promoter Is Functionally Associated with Acute Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation

J. Luis Espinoza, Akiyoshi Takami, Katsuya Nakata et al. · PLoS ONE · 2011 · 206 citations · Full text

Life Sciences, Genetics, Immunology +17

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group

Katsuto Takenaka, Tetsuya Nishida, Yuki Asano‐Mori et al. · Biology of Blood and Marrow Transplantation · 2015 · 194 citations · Full text

Medicine, Hematology, Immunology +15

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Shuichi Miyawaki, Shigeki Ohtake, Shin Fujisawa et al. · Blood · 2010 · 175 citations · Full text

Medicine, Oncology, Pharmacology +15

Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study

Kazuo Muroi, Koichi Miyamura, Masaya Okada et al. · International Journal of Hematology · 2015 · 170 citations

Life Sciences, Cell Biology, Immunology +14